BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20023913)

  • 1. Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines.
    Arambula JF; Sessler JL; Fountain ME; Wei WH; Magda D; Siddik ZH
    Dalton Trans; 2009 Dec; (48):10834-40. PubMed ID: 20023913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents.
    Thiabaud G; He G; Sen S; Shelton KA; Baze WB; Segura L; Alaniz J; Munoz Macias R; Lyness G; Watts AB; Kim HM; Lee H; Cho MY; Hong KS; Finch R; Siddik ZH; Arambula JF; Sessler JL
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7021-7029. PubMed ID: 32179677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate.
    Thiabaud G; Arambula JF; Siddik ZH; Sessler JL
    Chemistry; 2014 Jul; 20(29):8942-7. PubMed ID: 24961491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
    Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
    Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs.
    Jagodinsky JC; Sulima A; Cao Y; Poprawski JE; Blackman BN; Lloyd JR; Swenson RE; Gottesman MM; Hall MD
    J Biol Inorg Chem; 2015 Oct; 20(7):1081-95. PubMed ID: 26323351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New platinum (II) and palladium (II) complexes of coumarin-thiazole Schiff base with a fluorescent chemosensor properties: Synthesis, spectroscopic characterization, X-ray structure determination, in vitro anticancer activity on various human carcinoma cell lines and computational studies.
    Şahin Ö; Özdemir ÜÖ; Seferoğlu N; Genc ZK; Kaya K; Aydıner B; Tekin S; Seferoğlu Z
    J Photochem Photobiol B; 2018 Jan; 178():428-439. PubMed ID: 29216566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
    Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
    J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
    Ma L; Ma R; Wang Z; Yiu SM; Zhu G
    Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
    Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
    J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
    Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
    Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
    Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
    Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mithplatins: Mithramycin SA-Pt(II) Complex Conjugates for the Treatment of Platinum-Resistant Ovarian Cancers.
    Bhosale SS; Mandal A; Hou C; McCorkle JR; Schweer D; Hill KS; Subramanian V; Kolesar JM; Tsodikov OV; Rohr J
    ChemMedChem; 2023 Feb; 18(3):e202200368. PubMed ID: 36342449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
    Štarha P; Trávníček Z; Pazderová L; Dvořák Z
    J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor.
    Nakatake H; Ekimoto H; Aso M; Ogawa A; Yamaguchi A; Suemune H
    Chem Pharm Bull (Tokyo); 2011; 59(6):710-3. PubMed ID: 21628905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
    Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
    J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying the interactions of a platinum(II) 9-aminoacridine complex with proteins and oligonucleotides by ESI-TOF MS.
    Samper KG; Vicente C; Rodríguez V; Atrian S; Cutillas N; Capdevila M; Ruiz J; Palacios Ò
    Dalton Trans; 2012 Jan; 41(1):300-6. PubMed ID: 22089173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-Specific, Intracellular, Reductive Activation of Anticancer Pt
    Reshetnikov V; Daum S; Mokhir A
    Chemistry; 2017 Apr; 23(24):5678-5681. PubMed ID: 28319647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
    Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
    Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.